About ConsumerLab.com

Posted September 08, 2020

FDA Warns Seller of Opioid Withdrawal Supplement

On August 25, 2020, the FDA issued a warning letter to Renewal Supplements LLC following a review of the company's website, which found statements made about the company product Opi-Cure to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at www.consumerlab.com/join/